Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05101252 · ClinicalTrials.gov registry record · NA

Comparison of a Daily Disposable Multifocal Contact Lens to a Marketed Product

A NA study of Visual Acuity, sponsored by Johnson & Johnson Vision Care.

Completed
Registry status
NA
Development phase
77
Enrollment target
9
Study locations

NCT05101252 is a NA study of Visual Acuity that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 77 participants, below the 136-participant average among 20 other Visual Acuity trials with a reported enrollment target (43% lower). The trial reports 9 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05101252, a NA study of Visual Acuity, has completed, sponsored by Johnson & Johnson Vision Care.

COMPLETED
Registry status
NA
Development phase
77 participants
Enrollment target
9
Study locations

Study Summary

This is a single-masked, two-arm, parallel-group, randomized-controlled, dispensing clinical trial to evaluate the visual performance.

Conditions Studied

Interventions

  • DEVICE senofilcon A C3
  • DEVICE Dailies Total 1 Multifocal Contact Lenses

Study Locations (9)

Florida

  • Stam & Associates Eye Care - Jacksonville
  • Sabal Eye Care - Longwood

Georgia

  • Visual Eyes - Roswell

Kansas

  • Kannarr Eye Care - Pittsburg

Michigan

  • Birmingham Vision Care - Bloomfield Township

New York

  • Eye Associates of New York - New York

Ohio

  • ProCare Vision Centers - Granville

Rhode Island

  • West Bay Eye Associates - Warwick

Texas

  • Tyler Eye Associates - Tyler

Trial Details

FieldValue
Enrollment Target 77 participants
Start Date 2021-10-11
Est. Completion 2021-11-29
Phase NA

Sponsor

Johnson & Johnson Vision Care

142 total trials

What the Registry Record Tells You About NCT05101252

The ClinicalTrials.gov registry entry for NCT05101252 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 136-participant average among 20 other Visual Acuity trials with a reported enrollment target (43% lower). The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Visual Acuity appearing as the primary indexed condition, and to 2 interventions - of which senofilcon A C3 is the first listed.

NCT05101252 reports 9 study locations spanning 8 distinct geographic areas - top geographies include Florida, Georgia, Kansas.

Frequently Asked Questions

What is clinical trial NCT05101252 about?

NCT05101252 is a clinical study titled "Comparison of a Daily Disposable Multifocal Contact Lens to a Marketed Product". This is a single-masked, two-arm, parallel-group, randomized-controlled, dispensing clinical trial to evaluate the visual performance.

What is the current status of trial NCT05101252?

This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2021-10-11. Estimated completion is 2021-11-29.

What conditions does trial NCT05101252 study?

This clinical trial studies the following conditions: Visual Acuity.

What interventions are being tested in trial NCT05101252?

The interventions under investigation include: senofilcon A C3 (DEVICE), Dailies Total 1 Multifocal Contact Lenses (DEVICE).

Who is sponsoring clinical trial NCT05101252?

This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05101252 being conducted?

This trial has 9 study locations across Florida, Georgia, Kansas, Michigan, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Visual Acuity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.